Pricing Log in Create free account
Saturday 17 October 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

255.55 2.27 +0.90%
Market cap
$610.4B
P/E
29.6×
Fwd P/E
24.9×
Dividend yield
2.07%
F-score
3/9
Altman Z
4.78
Beneish M
−2.26
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Johnson & Johnson (JNJ) Current ratio

Alert me on Current ratio

Johnson & Johnson's current ratio at the end of the quarter to 30 June 2026 was 1.1×, up 0.1× from fiscal 2025 (1.0×). Over the past ten years it has ranged from 1.0× (fiscal 2022) to 2.5× (fiscal 2016); the current reading is higher than 18% of that period. That is below the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.0× (7.47%)
FY2024 1.1× (3.90%)
FY2023 1.2× 16.64%
FY2022 1.0× (26.51%)
FY2021 1.3× 11.82%
FY2020 1.2× (4.22%)
FY2019 1.3× (14.59%)
FY2018 1.5× 4.46%
FY2017 1.4× (42.96%)
FY2016 2.5× 14.00%

Quarterly newest first

Period Current ratio Change
Jun 2026 1.1× 6.21%
Mar 2026 1.0× (0.24%)
Dec 2025 1.0× (4.28%)
Sep 2025 1.1× 6.73%
42 more quarters

Against its own ten years

Low 1.0× High 2.5×
Ten-year median 1.3×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
AMGN Amgen Inc. compare 1.4×
LLY Eli Lilly and Company compare 1.4×
MRK Merck & Co., Inc. compare 1.3×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
JNJ Johnson & Johnson 1.1×
AZN AstraZeneca PLC compare 0.9×
NVS Novartis AG compare 0.9×
ABBV AbbVie Inc. compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on JNJ